在乳腺癌中核分子成像的当前方法
Laura Schäfer1, Betül Altunay1, Amelie Heesch1
1Department of Nuclear Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Cancers
|July 12, 2025
概括
最近的核分子成像技术的进步改善了膀癌 (BCa) 管理. 新的放射性标记探针增强了诊断,表征和治疗术策略,包括放射性连接体治疗.
科学领域:
- 核医学是一种核医学.
- 分子成像学分子成像学
- 在瘤学瘤学.
背景情况:
- 膀癌 (BCa) 管理需要准确的诊断和治疗工具.
- 核分子成像为BCa.提供了有希望的解决方案.
- 最近的进展显著提高了这些模式的价值.
研究的目的:
- 审查最近在膀癌 (BCa) 管理的核分子成像方面的进展.
- 突出这些技术的诊断和治疗价值.
- 探索新型放射性标记探针在BCa护理中的作用.
主要方法:
- 对过去2-3年的临床研究进行叙述性回顾.
- 专注于核分子成像技术的进步.
- 探索各种放射性标记探头及其应用.
主要成果:
- 最近的核分子成像技术显示了BCa的增强诊断能力.
- 这些方法可以更好地表征BCa.
- 已经证明了将其整合到放射性干疗法和治疗术策略中.
结论:
- 核分子成像在膀癌 (BCa) 管理中越来越有价值.
- 新型放射性标记探头对于准确的诊断和治疗至关重要.
- 使用这些成像技术的精神治疗方法提供了个性化的BCa护理.
相关概念视频
Imaging Studies II: Positron Emission Tomography and Scintigraphy
239
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
239
Positron Emission Tomography
5.8K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.8K


